A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
Article in Genome Medicine (September 2022)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Genome Medicine (September 2022)
Article in International Journal of Molecular Sciences (July 2022)
Article in International Journal of Cancer (June 2022)